Research summary ·
Risk of myocardial infarction in adults with gout treated with allopurinol: A systematic review and meta-analysis.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This review asked if allopurinol use is linked to heart attacks. Allopurinol is a drug used to lower urate. The people in the studies were adults with confirmed gout. The team searched PubMed, Scopus and Web of Science up to January 2026. They pooled results from studies that watched people but did not assign the drug. Each study had to adjust its results for other factors.
What they found
The team found 4 studies that looked back in time at groups of people. Pooled together, allopurinol use was linked to fewer heart attacks. The hazard ratio for this link was 0.84. But the link did not hold up in some extra checks. Without the study that carried the most weight, it was not clear. The same was true when allopurinol was compared with other active treatments. A stricter way to pool the data also gave an unclear result.
What it means for patients
The authors say allopurinol was linked to a modest drop in heart attack risk. They say this drop was significant in their main analysis. This link was seen in adults with gout. The study shows a link only, not that the drug caused it.
Why it is not certain yet
Only 4 studies were included. All of them looked back in time. One study carried the most weight in the main result. When it was left out, the link was not clear. Other checks also gave unclear results. Studies that only watch people cannot prove the drug caused the change.
Source
Risk of myocardial infarction in adults with gout treated with allopurinol: A systematic review and meta-analysis.
PubMed · PMID 42912780We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Gout publications